IPP Bureau
HCG Bengaluru pushes distress screening as ‘6th vital sign’ in cancer care
By IPP Bureau - April 09, 2026
The initiative aligns with global psycho-oncology standards that advocate routine distress screening as a core quality benchmark in cancer treatment
Dr. Jitendra Singh urges industry to step up R&D collaboration
By IPP Bureau - April 09, 2026
Minister highlights RDI fund, private participation in space and nuclear sectors, and calls for faster reforms to improve ease of research in India
Gilead to acquire Tubulis for up to $5 billion to strengthen its oncology portfolio
By IPP Bureau - April 09, 2026
The acquisition complements Gilead’s existing oncology expertise and development infrastructure
Halozyme strikes global deal with Vertex to expand Hypercon drug delivery technology
By IPP Bureau - April 09, 2026
The deal gives Vertex access to Halozyme’s Hypercon technology for up to three drug targets
RoosterBio taps MineBio to supercharge hMSC & exosome solutions in China
By IPP Bureau - April 09, 2026
Insmed’s Brensocatib fails to hit endpoints in hidradenitis suppurativa study
By IPP Bureau - April 09, 2026
The results were consistent across both the 10 mg and 40 mg treatment arms
Stereotaxis bags FDA clearance for next-gen cath lab tech
By IPP Bureau - April 09, 2026
Johnson & Johnson unveils Varipulse Pro in Europe for faster & safer heart procedures
By IPP Bureau - April 09, 2026
The new device promises faster, more efficient cardiac procedures while maintaining the safety and effectiveness clinicians expect
JP Nadda highlights preventive healthcare push on World Health Day
By IPP Bureau - April 08, 2026
Union Health Minister says India’s healthcare model blends traditional wisdom with modern science, backed by Ayushman Bharat and Janaushadhi expansion
Asia emerges new hotspot for healthcare ransomware, says report
By IPP Bureau - April 08, 2026
Cyble’s 2026 healthcare threat report flags a sharp rise in Asia-focused ransomware, with hospitals, elderly care, and diagnostic systems increasingly in cybercriminal crosshairs
Solara Active Pharma dispatches final rights share call notice; Rs 112.5 per share due by May 7
By IPP Bureau - April 08, 2026
API maker begins circulation of second and final call money notice for partly paid-up rights shares, completing the last leg of its 2024 fundraising cycle
Dabur reports steady domestic growth amid global headwinds in Q4 FY26
By IPP Bureau - April 08, 2026
The India FMCG business showed a sequential recovery and is expected to post high-single digit growth
Trialt and Viedoc team up to transform clinical trials
By IPP Bureau - April 08, 2026
The partnership aims to accelerate clinical trial timelines, boost data quality, and improve decision-making for sponsors worldwide
IndiaAI, CDSCO launch hackathon to accelerate health innovation approvals
By IPP Bureau - April 08, 2026
AI challenge offers Rs 10 lakh top prize and potential ?50 lakh deployment contract; applications open till April 17
Transgene and NEC join forces to advance personalized cancer vaccine
By IPP Bureau - April 08, 2026
TG4050 harnesses Transgene’s myvac platform and NEC’s AI-powered neoantigen prediction technology to tailor vaccines to each patient’s tumor
